SUCCINYLcholine Chloride 200 mg/ recalled over manufacturing violations
- Recall date
- July 10, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- New England Life Care, Inc. dba Advanced Compounding Solutions recalls SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitut…
- Recall number
- D-0926-2023
- FDA classification
- Class II
- Brand / firm
- New England Life Care, Inc. dba Advanced Compounding Solutions
- Sold / distributed
- Nationwide in the USA
Why it was recalled
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042; NDC: 71546-083-10
Get recall alerts
Free email alert whenever New England Life Care, Inc. dba Advanced Compounding Solutions has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: New England Life Care, Inc. dba Advanced Compounding Solutions